Evidence map›Paper›PMID 34440610›Full record

ArticleLife (Basel, Switzerland)2021

Identification of Targeted Proteins by Jamu Formulas for Different Efficacies Using Machine Learning Approach.

Sony Hartono Wijaya, Farit Mochamad Afendi, Irmanida Batubara, Ming Huang, Naoaki Ono, Shigehiko Kanaya, Md Altaf-Ul-Amin

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sony Hartono WijayaDepartment of Computer Science, IPB University, Kampus IPB Dramaga Wing 20 Level 5, Bogor 16680, Indonesia.ORCID 0000-0002-4603-6928
Farit Mochamad AfendiTropical Biopharmaca Research Center, IPB University, Kampus IPB Taman Kencana, Bogor 16128, Indonesia.
Irmanida BatubaraTropical Biopharmaca Research Center, IPB University, Kampus IPB Taman Kencana, Bogor 16128, Indonesia.ORCID 0000-0001-8201-7807
Ming HuangComputational Systems Biology Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-0192, Nara, Japan.
Naoaki OnoComputational Systems Biology Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-0192, Nara, Japan.
Shigehiko KanayaComputational Systems Biology Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-0192, Nara, Japan.
Md Altaf-Ul-AminComputational Systems Biology Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-0192, Nara, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe performed in silico prediction of the interactions between compounds of Jamu herbs and human proteins by utilizing data-intensive science and machine learning methods. Verifying the proteins that are targeted by compounds of natural herbs will be helpful to select natural herb-based drug candidates.

methodsInitially, data related to compounds, target proteins, and interactions between them were collected from open access databases. Compounds are represented by molecular fingerprints, whereas amino acid sequences are represented by numerical protein descriptors. Then, prediction models that predict the interactions between compounds and target proteins were constructed using support vector machine and random forest.

resultsA random forest model constructed based on MACCS fingerprint and amino acid composition obtained the highest accuracy. We used the best model to predict target proteins for 94 important Jamu compounds and assessed the results by supporting evidence from published literature and other sources. There are 27 compounds that can be validated by professional doctors, and those compounds belong to seven efficacy groups.

conclusionBy comparing the efficacy of predicted compounds and the relations of the targeted proteins with diseases, we found that some compounds might be considered as drug candidates.

Indexed as

compound–protein interactiondrug discoveryherbal medicineJamumachine learning

Identifiers

PMID34440610
PMCPMC8398944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.